We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$101B
AUM Growth
+$37.4B
(+59%)
Cap. Flow
+$36.7B
Cap. Flow
% of AUM
36.22%
Top 10 Holdings %
Top 10 Hldgs %
21.17%
Holding
5,633
New
1,585
Increased
2,056
Reduced
1,281
Closed
669
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
NVIDIA
NVDA
|
+$1.29B |
| 3 |
Apple
AAPL
|
+$690M |
| 4 |
Microsoft
MSFT
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.67B |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$204M |
| 3 |
SPDR Gold Trust
GLD
|
+$173M |
| 4 |
Costco
COST
|
+$161M |
| 5 |
Qualcomm
QCOM
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Financials | 3.61% |
| 4 | Healthcare | 3.25% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
CRISPR Therapeutics
CRSP
$4.68B
| $1.61M | ﹤0.01% |
40,800
+29,100
| +249% | +$1.37M |
|
2602
PUT
Helen of Troy
HELE
$672M
| $1.6M | ﹤0.01% |
+26,800
| New | +$1.78M |
|
2603
PUT
Agilent Technologies
A
$39.7B
| $1.6M | ﹤0.01% |
+11,900
| New | +$1.63M |
|
2604
Aptiv
APTV
$12.6B
| $1.6M | ﹤0.01% |
26,414
+19,259
| +269% | +$1.18M |
|
2605
PUT
Oceaneering
OII
$4.78B
| $1.6M | ﹤0.01% |
+61,200
| New | +$1.62M |
|
2606
PUT
Norfolk Southern
NSC
$76.1B
| $1.6M | ﹤0.01% |
6,800
+5,000
| +278% | +$1.27M |
|
2607
Alexandria Real Estate Equities
ARE
$9.41B
| $1.6M | ﹤0.01% |
16,359
-32,463
| -66% | -$3.56M |
|
2608
PUT
FirstEnergy
FE
$28.7B
| $1.6M | ﹤0.01% |
+40,100
| New | +$1.68M |
|
|
DVAX
2609
DELISTED
Dynavax Technologies
DVAX
| $1.59M | ﹤0.01% |
124,807
+104,325
| +509% | +$1.26M |
|
2610
Nutrien
NTR
$33.3B
| $1.59M | ﹤0.01% |
35,610
+668
| +2% | +$31.7K |
|
2611
PUT
Edwards Lifesciences
EW
$48.2B
| $1.59M | ﹤0.01% |
21,500
-58,000
| -73% | -$4.06M |
|
2612
Red Violet
RDVT
$938M
| $1.59M | ﹤0.01% |
43,928
+15,840
| +56% | +$528K |
|
2613
CALL
Grab
GRAB
$14.1B
| $1.59M | ﹤0.01% |
336,700
+36,700
| +12% | +$167K |
|
2614
PUT
Goodyear
GT
$2.12B
| $1.58M | ﹤0.01% |
+175,500
| New | +$1.6M |
|
2615
Eagle Materials
EXP
$6.86B
| $1.58M | ﹤0.01% |
6,387
-6,903
| -52% | -$1.99M |
|
2616
Oneok
OKE
$55.9B
| $1.58M | ﹤0.01% |
15,696
-2,789
| -15% | -$285K |
|
2617
ProShares Ultra QQQ
QLD
$12.2B
| $1.58M | ﹤0.01% |
29,114
-35,054
| -55% | -$1.88M |
|
2618
Vir Biotechnology
VIR
$1.49B
| $1.57M | ﹤0.01% |
214,263
+110,563
| +107% | +$872K |
|
2619
CALL
Global X Uranium ETF
URA
$5.41B
| $1.57M | ﹤0.01% |
58,700
+4,800
| +9% | +$147K |
|
2620
Warner Bros
WBD
$64.2B
| $1.57M | ﹤0.01% |
148,608
+88,537
| +147% | +$823K |
|
2621
CALL
Noble Corp
NE
$6.25B
| $1.57M | ﹤0.01% |
50,000
-90,000
| -64% | -$2.98M |
|
|
ARIS
2622
DELISTED
Aris Water Solutions
ARIS
| $1.57M | ﹤0.01% |
+65,516
| New | +$1.42M |
|
2623
PUT
Annaly Capital Management
NLY
$17.4B
| $1.57M | ﹤0.01% |
85,700
+73,800
| +620% | +$1.44M |
|
|
FIRY
2624
CALL
Firy Inc
FIRY
$154M
| $1.57M | ﹤0.01% |
311,700
+11,200
| +4% | +$59.7K |
|
2625
Sempra
SRE
$59.2B
| $1.57M | ﹤0.01% |
17,865
-16,026
| -47% | -$1.4M |
|
Similar funds
Squarepoint's Q4 2024 Portfolio in Review
As of Q4 2024, Squarepoint held 5,633 positions worth $101B, up 59% from $63.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint deployed $36.7B of net new capital in Q4 2024, opening 1,585 new positions and adding to 2,056 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.67B trimmed.
- Squarepoint's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
- Squarepoint added most to NVIDIA in Q4 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.67B.
- Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q4 2024, selling an estimated $86.3M.
- Squarepoint's ten largest holdings make up 21% of its $101B portfolio in Q4 2024.
- Squarepoint opened 1,585 new positions and closed 669 in Q4 2024.
- Squarepoint's portfolio value rose 59% quarter-over-quarter to $101B.
Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.